Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib

J Pediatr. 1993 Dec;123(6):1005-8. doi: 10.1016/s0022-3476(05)80403-2.

Abstract

A 7 1/2-year-old patient with glycogenosis type lb had chronic neutropenia, recurrent bacterial infections, and severe hypoglycemia in spite of continuous nasogastric feeding. She was treated with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation. Absolute neutrophil counts and platelet counts rapidly reached normal values, and infectious episodes were reduced. She resumed oral feeding after transplantation and had no subsequent hypoglycemic episodes.

Publication types

  • Case Reports

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Child
  • Female
  • Glycogen Storage Disease Type I / surgery
  • Glycogen Storage Disease Type I / therapy*
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Lenograstim
  • Liver Transplantation*
  • Recombinant Proteins / therapeutic use

Substances

  • Adjuvants, Immunologic
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Lenograstim